Cardiac resynchronization therapy and reduced risk of death and nonfatal heart failure events Martin G. St. John Sutton Clinical Trials Report 29 November 2009 Pages: 211 - 212
Statins in the prevention of heart failure after myocardial infarction Helene Glassberg OriginalPaper 29 November 2009 Pages: 215 - 219
β-Adrenergic receptor blockers and heart failure risk after myocardial infarction: A critical review Robert H. NeumayrPaul J. Hauptman OriginalPaper 29 November 2009 Pages: 220 - 228
Modulation of left ventricular dilation remodeling with epicardial restraint devices in postmyocardial infarction heart failure Veli K. TopkaraSrikanth KondareddyDouglas L. Mann OriginalPaper 29 November 2009 Pages: 229 - 235
Who should receive an implantable cardioverter-defibrillator after myocardial infarction? Stavros MountantonakisMathew D. Hutchinson OriginalPaper 29 November 2009 Pages: 236 - 244
Prevention of late postmyocardial infarction left ventricular remodeling: An update Farouk MookadamSherif E. Moustafa OriginalPaper 29 November 2009 Pages: 245 - 253
Tachycardia-mediated cardiomyopathy: Recognition and management Rakesh GopinathannairRenee M. SullivanBrian Olshansky OriginalPaper 29 November 2009 Pages: 257 - 264
Stress cardiomyopathy syndrome: A contemporary review Divya KapoorKevin A. Bybee OriginalPaper 29 November 2009 Pages: 265 - 271
Hyperkalemia in patients with heart failure: Incidence, prevalence, and management Akshay S. Desai OriginalPaper 29 November 2009 Pages: 272 - 280
Diastolic and systolic heart failure: Different stages or distinct phenotypes of the heart failure syndrome? Jean G. F. BronzwaerWalter J. Paulus OriginalPaper 29 November 2009 Pages: 281 - 286
Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: New insights from continuous monitoring devices Philip B. Adamson OriginalPaper 29 November 2009 Pages: 287 - 292
